ClinicalTrials.gg
RecruitingNCT07313657Updated Feb 17, 2026

Improving Care and Mental Well-Being for Adults With Heart Failure

An interventional study of Heart Failure and Mental Health Intervention (FRAME) in Heart Failure, Mental Health and Stress, sponsored by Bruyère Health Research Institute.. Recruiting at 9 sites in Canada. Open to participants aged 40 Years and older. Per ClinicalTrials.gov, last updated 2026-02-17.

Sponsored by Bruyère Health Research Institute. · Not applicable, Interventional, and Health services research

From the registry’s dates

  • Started Sep 2025; still recruiting 1 year 1 month later.
Phase
Not applicable
Study type
Interventional
Enrollment
7,300
Allocation
Not applicable
Ages
40 Years and older
Sex
All
01

Study summary

Heart failure is a high-risk, chronic condition that impacts patients' mental health. Approximately 50% of heart failure patients experience comorbid mental health conditions, such as stress, depression and anxiety, which affect their day-to-day lives. Despite this interconnection, the integration of mental health awareness and support into cardiac care remains limited. To address this gap, the FRAME (Foundation, Recognition, Awareness, Management, Engagement) intervention was co-designed by researchers, healthcare providers, health system decisionmakers, and patient partners. This pilot study evaluates the feasibility of implementing the FRAME intervention in pilot clinical sites within two health regions in Ontario, Canada, including team-based family medicine clinics, cardiac rehabilitation/specialist clinics, and emergency departments. Utilizing a pretest-posttest hybrid 1 model intervention design, this study evaluates process indicators and patient-focused outcomes through surveys and semi-structured qualitative interviews. Findings from this study will inform a future large scale cohort study and scalable integration of the FRAME tool into existing cardiac care pathways to enhance mental health awareness and support among heart failure patients.

02

Conditions studied

  • Heart Failure
  • Mental Health
  • Stress
  • Anxiety
  • Depression

Keywords

  • Heart Failure and Mental Health
03

In context

Heart Failure

6,331 studies on the registry are indexed under Heart Failure; 1,396 are open to participants now.

This study's planned enrollment of 7,300 is above the median of 76 across 4,049 interventional studies indexed under Heart Failure.

Browse Heart Failure studies →

Lead sponsor

Bruyère Health Research Institute. is the lead sponsor of 9 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
40 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

For Patients (Surveys and Optional Interviews):

  • Patients at risk of heart failure (e.g., irregular heartbeat, coronary artery disease, a past heart attack, high blood pressure that is being treated, cardiomyopathy), or with a self-reported/documented diagnosis of heart failure OR on the following list of medications :

    • Angiotensin receptor-neprilysin inhibitors (ARNI), called sacubitril-valsartan
    • Angiotensin converting enzyme inhibitors (ACEi), called "prils"
    • Angiotensin-receptor blockers (ARBs), called "sartans"
    • Beta-blockers, called "lols"
    • Mineralocorticoid receptor antagonists (MRAs)
    • Sodium-glucose co-transporter-2 (SGLT2) inhibitors, called "flozins"
  • Receiving care at one of the participating pilot test sites or if they found their way to the tool website
  • Willing and able to provide and name, email address and phone number for follow-up contact (for survey and interview)

Caregivers (Optional interviews):

  • Caregivers who support adult(s) with heart failure.

Exclusion criteria

Exclusion Criteria:

  • Inability to provide (e.g., due to cognitive impairment or language barriers without translated support)
  • Participants who do not have access to the internet will not be able to use the web-tool.

For Healthcare Providers

  • Providers that are not involved in the care of heart failure patients
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
7,300 participants (estimated)

Study arms

  • Other
    FRAME Intervention

    Every participant who completed the intake survey for baseline data collection will receive the FRAME intervention via email in April 2026.

    Other: Heart Failure and Mental Health Intervention (FRAME)

Interventions

  • OtherHeart Failure and Mental Health Intervention (FRAME)

    Foundation, Recognition, Awareness, Management and Engagement (FRAME) is a multi-component, co-designed web tool created in collaboration with patient partners, caregivers, healthcare providers, and Archipel and Great River Ontario Health Teams. It is designed to improve recognition, awareness, management and support for mental health in patients with heart failure. There are three different versions: one for healthcare providers, one for caregivers and one for patients. The intervention includes educational material about heart failure and mental health, conversational support to help facilitate discussions about mental health, self-management activity maps (e.g., tips about nutrition and exercise), asset maps (i.e., displaying available resources), and the provider-facing discussion tool to help initiate conversations about mental health and guide referrals or supports. FRAME was developed through a co-design process informed by the lived experiences of community partners.

06

What researchers measure

Primary outcomes

  1. Frequency of Mental Health Conversations

    This outcome measures whether patients with heart failure report having a discussion about mental health with their healthcare provider or loved ones after being introduced to FRAME. This will be measured by changes in response to two questions in a survey given to participants pre- and post-intervention. These questions will ask if in the past 6 months, they have discussed mental health with a healthcare provider or if in the past 6 months, they have discussed mental health with their loved ones. The responses will include strongly disagree, disagree, neutral, agree and strongly agree. The intervention will be rolled out, after which they can respond to the post-intervention survey anytime until the study closes. Change in response from pre-intervention to post-intervention will be assessed.

    Time frame: Baseline, and up to 6 months following intervention

Secondary outcomes

  1. Engagement in Health Seeking Behaviours

    This outcome evaluates whether participants (patients) report accessing mental health-related support, following the FRAME intervention. Supports may include formal resources (e.g., referrals to psychological services), informal or community-based support (e.g., peer groups, faith-based programs), and self-management strategies (e.g., mindfulness, exercise, online tools). This outcome will be measured in pre-post intervention surveys with the participants. The question will ask if, in the past 6 months, they have used community-based supports or if, in the past 6 months, they have used self-management strategies. Below these questions, there will be a list of the supports/strategies, and beside them will be checkboxes with the frequency of access. The options for this will be N/A, never, once, 2-3 times, every month and weekly or more. Change in response from pre-intervention to post-intervention will be assessed.

    Time frame: Baseline, and up to 6 months following intervention

  2. Confidence in Engaging in Mental Health Conversations and Knowledge of Mental Health

    This outcome assesses perceived knowledge of the interconnection between mental health and heart failure through self-reported confidence in initiating mental health discussions. This outcome will be assessed through pre- and post-intervention surveys. The question assessing perceived knowledge of mental health will be about whether they know where to find information/support about mental health in their community. The question assessing confidence in engaging in mental health conversations will ask if they feel confident bringing up my mental health with a healthcare provider in a medical setting. Both questions will have checkbox options from strongly disagree to strongly agree, where a change in responses will be assessed from pre-intervention to post-intervention.

    Time frame: Baseline, and up to 6 months following intervention

07

Study locations

3 of 9 sites recruiting
  • Seaway Valley Community Health Centre (Cardiac Rehab Program)
    Cornwall, Ontario, Canada
    Recruiting
  • Centre de Santé Communautaire de l'Estrie
    Limoges, Ontario, Canada
    Active, not recruiting

    Not enrolling at this site.

  • Orleans Cardiopulmonary Clinic
    Orléans, Ontario, Canada
    Recruiting
  • Bruyère Health Research Institute
    Ottawa, Ontario K1N 5C8, Canada
    Not yet recruiting
    • Krystal Kehoe MacLeod Principal Investigator · Contactkmacleod@bruyere.org · 613-862-4314
    • Krystal Kehoe MacLeod Principal Investigator · Principal investigator
  • Byward Family Health Team
    Ottawa, Ontario, Canada
    Not yet recruiting
  • Montfort Hospital, and associated Aline-Chrétien Rehabilitation Clinic
    Ottawa, Ontario, Canada
    Active, not recruiting

    Not enrolling at this site.

  • Ste-Anne Medical Clinic
    Ottawa, Ontario, Canada
    Active, not recruiting

    Not enrolling at this site.

  • University of Ottawa Heart Institute
    Ottawa, Ontario, Canada
    Active, not recruiting

    Not enrolling at this site.

  • Winchester Memorial Hospital
    Winchester, Ontario, Canada
    Recruiting
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: Undecided — We currently have no motivation for sharing IPD, but if our data becomes helpful for the conduction of a follow-up project, IPD may be shared.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Sep 2025 (actual). Primary completion is estimated for Nov 2026, 14 months after the start.

Of 1,118 non-industry interventional studies with no phase under Heart Failure, half reached primary completion within 29 months of starting (the median), counting those still running; a quarter within 16 and three quarters within 50. This study's planned 14 months is below that.

Counting every sponsor, half of 1,354 studies reached it within 31 months; a quarter within 16 and three quarters within 52.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 23, 2025
First posted
Jan 2, 2026
StartActual
Sep 26, 2025
Primary completionEst.
Nov 30, 2026
CompletionEst.
Nov 30, 2026
Last update
Feb 17, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 17, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07313657
Lead sponsor
Bruyère Health Research Institute.
Collaborators
Canadian Institutes of Health Research (CIHR)
Responsible party
Sponsor
First posted
Jan 2, 2026
Start date
Sep 26, 2025
Primary completion
Nov 30, 2026 (estimated)
Completion
Nov 30, 2026 (estimated)
Last update
Feb 17, 2026

Study contacts

Krystal Kehoe MacLeod, PhD
Contact
kmacleod@bruyere.org
613-862-4314

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion